Andrew Baum, MD, has served as the head of global healthcare and managing director of equity research at Citi, where he’s been working since 2011. In June, he will join Pfizer and succeed Aamir Malik, who recently became the drugmaker’s chief U.S. commercial officer, executive vice president.
In his new role, Dr. Baum will lead Pfizer’s portfolio management team, the company said in a news release.
Before Citi, Dr. Baum covered European Pharmaceuticals at Morgan Stanley for 14 years; prior to that role, he was a physician.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
